CIK 0001657677
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Parabilis Medicines, Inc.
Sign in to watch- Ticker
- PBLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474505725
- Phone
- +1 617-945-9510
- Business address
- 30 ACORN PARK DRIVE, 6TH FLOOR, CAMBRIDGE, MA, 02140
- Former names
- FOG PHARMACEUTICALS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | Flynn James E 10% owner | Conversion | +122,990 | 122,990 | ||
| 2026-06-11 | Flynn James E 10% owner | Conversion | +122,990 | 122,990 | ||
| 2026-06-11 | Flynn James E 10% owner | Conversion | +149,238 | 272,228 | ||
| 2026-06-11 | Flynn James E 10% owner | Conversion | +149,238 | 272,228 | ||
| 2026-06-11 | Flynn James E 10% owner | Conversion | +260,992 | 533,220 | ||
| 2026-06-11 | Flynn James E 10% owner | Conversion | +260,992 | 533,220 | ||
| 2026-06-11 | Flynn James E 10% owner | Conversion | +407,132 | 940,352 | ||
| 2026-06-11 | Flynn James E 10% owner | Conversion | +407,132 | 940,352 | ||
| 2026-06-11 | Flynn James E 10% owner | Conversion · Series A Preferred Stock | −166,070 | 0 | ||
| 2026-06-11 | Flynn James E 10% owner | Conversion · Series A Preferred Stock | −166,070 | 0 | ||
| 2026-06-11 | Flynn James E 10% owner | Conversion · Series B Preferred Stock | −143,650 | 0 | ||
| 2026-06-11 | Flynn James E 10% owner | Conversion · Series B Preferred Stock | −143,650 | 0 | ||
| 2026-06-11 | Flynn James E 10% owner | Conversion · Series C Preferred Stock | −246,732 | 0 | ||
| 2026-06-11 | Flynn James E 10% owner | Conversion · Series C Preferred Stock | −246,732 | 0 | ||
| 2026-06-11 | Flynn James E 10% owner | Conversion · Series D Preferred Stock | −464,550 | 0 | ||
| 2026-06-11 | Flynn James E 10% owner | Conversion · Series D Preferred Stock | −464,550 | 0 |
Page 1 of 1 · 16 trades